24 March 2026 - Top Stories

HeartSight, powered by Oracle's AI stack, cuts echocardiogram diagnosis time by more than 80% in Australian pilots, signaling a shift in how clinics handle imaging analysis.

Interoperability is moving from aspiration to practice as AU eRequesting Release 1.0 establishes the first national FHIR standard for diagnostic requests, with real deployments to pathology and radiology easing paper-based workflows.

Governance of the AI stack becomes a core risk issue; Aspen Medical argues that care requires end-to-end governance across tools that share data with the EMR, not isolated tool checks, or cascading errors could hit patient safety.

Policy and funding signals in primary care, including NSW rebates for Level C and D GP visits and forthcoming reforms on referrals, will push clinics toward digital tools and smoother clinician-to-clinician workflows, though execution timelines will matter for uptake.

Flinders University’s vision-enabled AI scribes show 98% accuracy in simulated interviews, highlighting how visual context improves data capture and setting a higher bar for real-world validation and regulatory alignment.

• Hospitals adopting HeartSight built on Oracle's 26ai and OCI Data Science must implement enterprise governance to maintain auditability.
• Biotech firms will exploit WEHI's 672 high-confidence E3 ligases atlas for target discovery, but licensing terms for commercial use remain unclear.
• Vendors must align with AU eRequesting Release 1.0 to deliver interoperable diagnostic requests; early adopters can realise faster return on investment.
• Health system leaders should establish end-to-end governance across AI tools integrated with the EMR; vendors relying on isolated validation will lose credibility in a safety-first market.
• NSW and ACT GPs gain higher rebates for Level C and D consultations; practice finance and patient access to care improve, encouraging digital tool adoption.
• Clinics piloting vision-enabled scribes must pursue rigorous validation and regulator-aligned deployment to avoid safety concerns delaying rollout.
• Onshore PBS stockholding reinforces medicine access for patients, while suppliers bear higher storage costs and tighter margins.